Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Cycloleucine

SKU: orb1940166

Description

Cycloleucine is an antagonist of NMDA receptor associated glycine receptor with a Ki of 600 μM. Cycloleucine is also a competitive inhibitor of S-adenosyl-methionine mediated methylation with anxiolytic and cytostatic effects.(In Vitro):Cytostatic (10 μg/mL) inhibits the viability of human KB and mouse L1210s leukemia cell lines. Cycloleucine (4-40 mM; 3 h) blocks internal methylation of viral RNA in B77 transformed chick embryo fibroblasts. Cycloleucine (40 mM; 24 h) blocks the formation of both m6A and the penultimate Gm in B77 38S RNA subunits by greater than 90%.(In Vivo):Cycloleucine (0.5, 1.0, 2.0, 4 μg/μL; intracerebroventrically) increases time spent in open arms, open arm entries, and extreme arrivals in rats. In Semliki Forest virus strain A7(74) infected and control mice, Cycloleucine reduces thymus and spleen weights.

Images & Validation

Key Properties

CAS Number52-52-8
MW129.159
Purity>98% (HPLC)
FormulaC6H11NO2
SMILESNC1(CCCC1)C(O)=O
TargetNMDAR
SolubilityIn Vitro: H2O : 20 mg/mL (154.85 mM)

Bioactivity

In Vivo
Cycloleucine (0.5-4 μg; intracerebroventrical injection) increases time spent in open arms, open arm entries, and extreme arrivals in rats. Cycloleucine reduces thymus and spleen weights in Semliki Forest virus (SFV) strain A7(74) infected and control mice. Animal model: Male rats bilaterally cannulated into the nucleus accumbens septi (NAS). Dosage: 1 μL of 0.5, 1.0, 2.0, 4 μg/μL. Administration: Intracerebroventrical injection. Result: Increased time spent in the open arms and extreme arrivals at all doses. Increased open arm entries at the dose of 4 μg.
In Vitro
Cycloleucine (4-40 mM; 3 h) blocks internal methylation of viral RNA in B77 transformed chick embryo fibroblasts. Cycloleucine (40 mM; 24 h) blocks the formation of both m6A and the penultimate Gm in B77 38S RNA subunits by greater than 90%. Cytostatic (10 μg/mL) inhibits the viability human KB and mouse L1210s leukemia cell lines.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Cycloleucine-CoA [orb3143858]

    50 mg, 10 mg
  • Cycloleucine [orb1297971]

    99.90% (May vary between batches)

    52-52-8

    129.16

    C6H11NO2

    25 mg, 50 mg, 100 mg, 500 mg, 1 g
  • Boc-cycloleucine [orb2940337]

    35264-09-6

    229.2729

    C11H19NO4

    10 g, 50 g, 5 g
  • 1-(Cbz-amino)cyclopentanecarboxylic acid [orb3021947]

    17191-44-5

    263.289

    C14H17NO4

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Cycloleucine (orb1940166)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

25 mg
$ 80.00
50 mg
$ 100.00
100 mg
$ 140.00
200 mg
$ 180.00
500 mg
$ 280.00